Screening aortic drug treatments through arterial compliance measurements

Current Vascular Pharmacology

Volumn 6, Issue 4, 2008, Pages 250-257

  Rentschler, Mark E ^a   Baxter, B Timothy ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Abdominal aortic aneurysm; Arterial compliance; Pharmacological treatment; Wall strength

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXYCYCLINE; ELASTIN; FIBRILLAR COLLAGEN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; TETRACYCLINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; CARDIOVASCULAR AGENT;

ABDOMINAL AORTA ANEURYSM; AORTA RECONSTRUCTION; AORTA WALL; ARTERY COMPLIANCE; ARTERY DIAMETER; CLINICAL TRIAL; DEATH; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; ELECTIVE SURGERY; ENDOVASCULAR SURGERY; ENZYME ACTIVITY; ENZYME INHIBITION; HEALTH CARE COST; HUMAN; HYPERTENSION; INCIDENCE; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PRIMARY PREVENTION; PROTEIN FUNCTION; REIMBURSEMENT; REVIEW; SCREENING TEST; THERAPY EFFECT; ANIMAL; ANIMAL MODEL; AORTA; AORTA RUPTURE; BIOLOGICAL MODEL; COMPLIANCE (PHYSICAL); DISEASE COURSE; DRUG EFFECT; MASS SCREENING; MEDICAL RESEARCH; METHODOLOGY; MOUSE; PATHOLOGY; PATIENT SELECTION; TREATMENT OUTCOME; VASCULAR SURGERY;

ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; BIOMEDICAL RESEARCH; CARDIOVASCULAR AGENTS; COMPLIANCE; DISEASE PROGRESSION; DOXYCYCLINE; HUMANS; MASS SCREENING; MICE; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; PATIENT SELECTION; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 55449095004     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016108785909751     Document Type: Review

References (70)

1. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, et al. Use of Doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 2001; 34: 606-10.
2. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, Kuller LH, O'Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996; 16: 963-70.
3. Ernst CB. Current therapy for infrarenal aortic aneurysms. N Engl J Med 1997; 336(1): 59-60.
4. Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC. Suggested standards for reporting on arterial aneurysms. J Vasc Surg 1991; 13: 452-8.
5. Stanley JC, Barnes RW, Ernst CB, Hertzer NR, Mannick JA, Moore WS. Vascular surgery in the United States: workforce issues. J Vasc Surg 1996; 23: 172-81.
6. Ernst CB. Current concepts: abdominal aortic aneurysm. N Engl J Med 1993; 328: 1167-72.
7. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Acher CW, Ballard DJ. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 1997; 126: 441-9.
8. Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2005; 142: 203-11.
9. Pleumeekers HJCM, Hoes AW, van der Does E, van Urk H, Hofman A, de Jong PTVM, Grobbee DE. Aneurysms of the abdominal aorta in order adults: the Rotterdam Study. Am J Epidemiol 1995; 142: 1291-9.
10. Scott RAP, Wilson NM, Ashton HA, Kay B. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg 1995; 82: 1066-70.
11. Semmens JB, Norman PE, Lawrence-Brown MM, Bass AJ, Holman CD. Population-based record linkage study of the incidence of abdominal aortic aneurysm in Western Australia in 1985-1994. Br J Surg 1998; 85: 648-52.
12. Strachan DP. Predictors of death from aortic aneurysm among middle-aged men: the Whitehall Study. Br J Surg 1991; 78: 401-4.
13. Reed D, Reed C, Stemmermann G, Hayashi T. Are aortic aneurysms caused by atherosclerosis? Circulation 1992; 85: 205-11.
14. Cole CW, Hill GB, Bouchard AG, Moher D, Farzad E, Rody K, Shea B. Atherosclerosis risk factors in abdominal aortic aneurysm and peripheral vascular occlusive disease. Chron Dis Can 1994; 15: 120-2.
15. Franks PJ, Edwards RJ, Greenhalgh RM, Powell JT. Risk factors for abdominal aortic aneurysms in smokers. Eur J Vasc Endovasc Surg 1996; 11: 487-92.
16. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994; 330: 1335-41.
17. Salim MA, Alpert BS, Ward JC, Pyeritz RE. Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan, syndrome. Am J Cardiol 1994; 74: 629-33.
18. Lindholt JS, Henneburg EW, Juul S, Fasting H. Impaired results of a randomized double blinded clinical trial of propranolol vs placebo on the expansion rate of small abdominal aortic aneurysms. Int Angiol 1999; 18: 52-7.
19. Propranolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg 2002; 35: 72-9.
20. Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan WD Jr, Blebea J, Littooy FN, et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 2002; 287: 2968-72.
21. Cronenwett JL, Murphy TF, Zelenock GB, Whitehouse WM Jr, Lindenauer SM, Graham LM. Actuarial analysis of variables associated with rupture of small abdominal aortic aneurysms. Surgery 1985; 98: 472-483.
22. Ouriel K, Green RM, Donayre C, Shortell CK, Elliott J, De Weese JA. An evaluation of new methods of expressing aortic aneurysm size: relationship to rupture. J Vasc Surg 1991; 15: 12-20.
23. Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. Ann Surg 1999; 230: 289-97.
24. Nicholls SC, Gardner JB, Meissner MH, Johansen HK. Rupture in small abdominal aortic aneurysms. J Vasc Surg 1998; 28: 884-8.
25. Lindholt JS, Vammen S, Fasting H, Henneberg EW. Psychological consequences of screening for abdominal aortic aneurysm and conservative treatment of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000; 20: 79-83.
26. Bertges DJ, Zwolak RM, Deaton DH, Teigen C, Tapper S, Koslow AR, Makaroun MS. Current hospital costs and medicare reimbursement for endovascular abdominal aortic aneurysm repair. J Vasc Surg 2003; 37: 272-9.
27. Prinssen M, Buskens E, Blankensteijn JD. Quality of life endovascular and open AAA repair. Results of a randomised trial. Eur J Vasc Endovasc Surg 2004; 27: 121-7.
28. Bown MJ, Sutton AJ, Bell PR, Sayers RD. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg 2002; 89: 714-30.
29. UK small aneurysm trial participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346: 1445-52.
30. Lederle FA, Johnson GR, Wilson SE, Acher CW, Ballard DJ, Littooy FN, Messina LM. Aneurysm Detection and Management Veterans Affairs Cooperative Study. Quality of life, impotence, and activity level in a randomized trial of immediate repair vs surveillance of small abdominal aortic aneurysm. J Vasc Surg 2003; 38: 745-52.
31. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2002; 105: 1641-9.
32. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110: 625-32.
33. Hovsepian DM, Ziporin SJ, Sakurai MK, Lee JK, Curci JA, Thompson RW. Elevated plasma levels of matrix metalloproteinase- 9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 2000; 11: 1345-52.
34. McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 1997; 96: 2228-32.
35. Golub LM, Wolff M, Lee HM, McNamara TF, Ramamurthy NS, Zambon J, Ciancio S. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985; 20: 12-23.
36. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res 1983; 18: 516-26.
37. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987; 66: 1310-4.
38. Liu J, Xiong W, Baca-Regen L, Nagase H, Baxter BT. Mechanism of inhibition of matrix metalloproteinase-2 expression by Doxycycline in human aortic smooth muscle cells. J Vasc Surg 2003; 38: 1376-83.
39. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase- induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996; 23: 336-46.
40. Rentschler M, Baxter BT. Pharmacological Approaches to Prevent Abdominal Aortic Aneurysm Enlargement and Rupture. Ann NY Acad Sci 2006; 1085: 39-46.
41. Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, Baxter BT. Doxycycline in patients with AAA and in mice: Comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 2002; 35: 923-9.
42. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, Sicard GA, Thompson, RW. Preoperative treatment with Doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 2000; 31(2): 325-42.
43. Kim HS, Luo L, Pflugfelder SC, Li DQ. Doxycycline inhibits TGFbeta1- induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2005; 46: 840-8.
44. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet Mar 2003; 33(3): 407-11.
45. Dawson J, Choke E, Sayed S, Cockerill G, Loftus I, Thompson MM. Pharmocotherapy of abdominal aortic aneurysms. Curr Vasc Pharmacol 2006; 4: 129-49.
46. EVAR Trial Participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR Trial 2): randomized controlled trial. Lancet 2005; 365: 2187-92.
47. Li Z, Kleinstreuer C. A new wall stress equation for aneurysmrupture prediction. Ann Biomed Engr 2005; 33: 209-13.
48. Raghavan ML, Webster MW, Vorp DA. Ex vivo biomechanical behavior of abdominal aortic aneurysm: assessment using a new mathematical model. Ann Biomed Eng 1996; 24: 573-82.
49. Raghavan ML, Vorp DA. Toward a biomechanical tool to evaluate rupture potential of abdominal aortic aneurysm: identification of a finite strain constitutive model and evaluation of its applicability. J Biomechanics 2000; 33: 475-82.
50. Thubrikar MJ, Labrosse M, Robicsek F, Al-Soudi J, Fowler B, Mechanical properties of abdominal aortic aneurysm wall. J Med Eng Tech 2001; 25: 133-42.
51. Di Martino ES, Bohra A, Vande Geest JP, Gupta N, Makaroun MS, Vorp DA. Biomechanical properties of ruptured vs electively repaired abdominal aortic aneurysm wall tissue. J Vasc Surg 2006; 43(3): 570-6.
52. Kyriacou SK, Humphrey JD. Influence of size, shape, and properties on the mechanics of axisymmetric saccular aneurysms. J Biomech 1996; 29: 1015-22.
53. Seshaiyer P, Humphrey JD. On the potentially protective role of contact constraints on saccular aneurysms. J Biomech 2001; 34: 607-12.
54. David G, Humphrey JD. Further evidence for the dynamic stability of intracranial saccular aneurysms. J Biomech 2003; 36, 1143-50.
55. Raghavan ML, Vorp DA. Wall stress distribution on three-dimensionally reconstructed models of human abdominal aortic aneurysm. J Vasc Surg 2000, 31: 760-9.
56. Fillinger MF, Raghavan ML, Marra SP. In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J Vasc Surg 2002; 36: 589-97.
57. Venkatasubramaniam AK, Fagan MJ, Mehta T, Mylankal K, Ray B, Kuhan G, Chetter P, McCollum P. A comparative study of aortic wall stress using finite element analysis for ruptured and non-ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2004; 28: 168-76.
58. Vorp DA, Lee PC, Wang DHJ, Makaroun MS, Nemoto EM, Ogawa S, Webster MW. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 2001; 34: 291-9.
59. DiMartino ES, Vorp DA. Effect of variation in intraluminal thrombus constitutive properties on abdominal aortic aneurysm wall stress. Ann Biomed Eng 2003; 31: 804-809.
60. Hoshina K, Nakahashi TK, Sho E, Sho M, Tsao P, Dalman RL. Aortic wall shear stress modulates aneurysm cellularity and structure. J Vasc Surg 2003; 37: 1067-74.
61. Khanafer KM, Gadhoke P, Berguer R, Bull JL. Modeling pulsatile flow in aortic aneurysms: effect of non-Newtonian properties of blood. Biorheology 2006; 43: 661-79.
62. Li Z, Kleinstreuer C. Effects of blood flow and vessel geometry on wall stress and rupture risk of abdominal aortic aneurysms. J Med Eng Technol 2006; 30: 283-97.
63. Raghavan ML, Ma B, Fillinger MF. Non-invasive determination of zero-pressure geometry of arterial aneurysms. Ann Biomed Eng 2006; 34: 1414-9.
64. Baxter BT, Davis VA, Minion DJ, Wang YP, Lynch TG, McManus BM. Abdominal aortic aneurysms are associated with altered matrix proteins of the nonaneurysmal aortic segments. J Vasc Surg 1994; 19: 797-802.
65. Burton AC. Relation of structure to function of tissues of wall of blood vessels. Physiol Rev 1954; 34: 619.
66. Humphrey JD, Kang T, Sakarda P, Anjanappa M. Computer-aided vascular experimentation: a new electromechanical test system. Ann Biomed Eng 1993; 21: 33-43.
67. Humphrey JD, Cardiovascular Solid Mechanics, Springer-Verlag New York, Inc. 2002; New York, NY.
68. Vaishnav RN, Young JT, Patel DJ. Distribution of stresses and strain-energy density through the wall thickness in a canine aortic segment. Circ Res 1973; 32: 577-83.
69. Rentschler M, Baxter BT. Preliminary Murine Aortic Tissue Material Properties from Pressure-Diameter Experiments. ASME Summer Bioengineering Conference 2007; Keystone, CO.
70. Fung YC. Biomechanics: Mechanical Properties of Living Tissues. Springer Science and Business Media, Inc. 1993; New York, NY.